Common immune-related risk factors and incident non-Hodgkin lymphoma: The multiethnic cohort
โ Scribed by Eva Erber; Unhee Lim; Gertraud Maskarinec; Laurence N. Kolonel
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 93 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Severe immune dysfunction is an established risk factor of lymphoma, but the role of moderate alterations of immunity is not clear and prospective investigations are needed. We examined several immuneโrelated disorders and medications in relation to nonโHodgkin lymphoma (NHL) in the Multiethnic Cohort. Over 215,000 subjects of African American, Caucasian, Japanese American, Latino and Native Hawaiian ancestry aged 45โ75 years completed a questionnaire, including information on medical history, in 1993โ1996. After exclusions, we performed Cox regression among 193,050 cohort members including 939 incident NHL cases while adjusting for sex, age, ethnicity, education, body mass index and alcohol intake. Selfโreported diabetes was not associated with NHL overall, but was positively associated with risk among Japanese Americans [hazard ratio (HR) = 1.55; 95% confidence interval (CI): 1.10โ2.17]. Participants with a history of blood transfusion were at increased risk with HR = 1.39 (95% CI: 1.06โ1.84) in men and HR = 1.22 (95% CI: 0.94โ1.58) in women, especially for the diffuse large Bโcell lymphoma subtype. History of asthma or other allergies was associated with elevated risk only among Latinos (HR = 1.46; 95% CI: 1.07โ2.00) who also showed a significant relation between current use of antihistamines and NHL (HR = 1.80; 95% CI: 1.09โ2.97). Use of nonsteroidal antiโinflammatory drugs was not associated with NHL. Our findings from this large prospective study support a moderate risk for NHL related to blood transfusions, current longโterm antihistamine use and diabetes, but the associations were limited to certain ethnic groups and require further replications. ยฉ 2009 UICC
๐ SIMILAR VOLUMES
## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m